BiotechTube
AccendoWave

AccendoWave

San Francisco, United States· Est.
accendowave.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

AccendoWave is a private, early-stage medical device company founded in 2019 and headquartered in San Francisco. It has developed a commercial-stage, non-invasive neuromodulation system designed as an opioid alternative for pain management, leveraging EEG-based biofeedback and software. The company appears to be in early commercial deployment, with a published case study involving Samsung and references to hospital trials, positioning it to address stringent hospital pain management requirements. Its business model likely involves the sale or lease of its hardware and software system to healthcare institutions.

Pain Management

Technology Platform

Integrated neuromodulation platform using a wearable EEG headband, tablet, and proprietary AI software to provide closed-loop neurofeedback for pain reduction.

Opportunities

The opioid crisis and regulatory mandates (e.g., Joint Commission requirements) create a powerful, compliance-driven demand for non-pharmaceutical pain solutions in hospitals.
The growing acceptance of digital therapeutics and wearable biofeedback devices opens a large market in both acute care and chronic pain management.

Risk Factors

The company requires more extensive clinical validation and peer-reviewed data to achieve widespread medical adoption and reimbursement.
As an early commercial-stage startup, it faces significant competition from other neuromodulation devices and digital health platforms, alongside execution risks in sales, marketing, and fundraising.

Competitive Landscape

AccendoWave competes in the non-invasive neuromodulation and digital pain therapeutic space, facing competition from other EEG-based neurofeedback systems (e.g., Muse, NeuroFlow), transcutaneous electrical nerve stimulation (TENS) devices, and a growing array of prescription digital therapeutics (PDTs) for pain. Its differentiation lies in its specific focus on clinical/hospital settings and its integrated hardware-software platform.

More companies in Digital Health & Biotech SaaS →More companies in United States →